Frontage Holdings Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FGHQF research report →
About the company
Frontage Holdings Corporation operates as a contract research organization, furnishing an extensive array of laboratory and associated services to pharmaceutical, biotechnology, and agrochemical firms, in addition to conducting bioequivalence studies. Its service portfolio includes laboratory testing, covering method development, validation, sample analysis, and central laboratory functions. The company also delivers chemistry, manufacturing, and control (CMC) services, which involve assisting with drug product development and analysis, alongside the provision and supply of materials for clinical trials.
- CEO
- Zhongping Lin
- IPO
- 2020
- Employees
- 1,560
- HQ
- Exton, PA, US
Price Chart
- Market Cap
- $273.74M
- P/E
- 37.43
- P/S
- 0.99
- P/B
- 0.73
- EV/EBITDA
- 8.22
- Div Yield
- 0.00%
- Gross Margin
- 26.96%
- Op Margin
- 6.26%
- Net Margin
- 2.65%
- ROE
- 1.98%
- ROIC
- 1.90%
- Revenue
- $257.07M · 0.85%
- Net Income
- $6.80M · 760.06%
- EPS
- $0.00 · 750.00%
- Op Income
- $14.58M
- FCF YoY
- 114.56%
- 52W High
- $0.15
- 52W Low
- $0.10
- 50D MA
- $0.14
- 200D MA
- $0.15
- Beta
- 0.15
- Avg Volume
- 2.90K
Get TickerSpark's AI analysis on FGHQF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FGHQF coverage
Recent articles, reports, and earnings notes.
No research on FGHQF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FGHQF report →Similar companies
Peers in the same neighborhood.